Pcn213 - Financing Expensive Anticancer Drugs in Hospitals: Towards Transparency to Improve Patient Access

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.295
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pcp68 - Medical Access Strategy to Improve Access to Innovative and Expensive Therapy in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Reimbursement of Expensive Drugs in Hospitals in Western European Countries

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Static and Dynamic Appointment Scheduling to Improve Patient Access Time

Health Systems
Health Information ManagementHealth PolicyComputer Science ApplicationsHealth Informatics
2017English

Towards Transparency

Nature Geoscience
EarthPlanetary Sciences
2014English

Impact of the Healthcare Payment System on Patient Access to Oral Anticancer Drugs: An Illustration From the French and United States Contexts

BMC Health Services Research
Health Policy
2014English

Access to Medication in Mexico: Financing and Equity

HORIZONTE SANITARIO
2016English

Medical Paternalism and Expensive Unsubsidised Drugs

BMJ
2005English

Catching Up to the Crisis: Opportunities for Pediatric Hospitals to Improve Children’s Access to Mental Health Services

Hospital pediatrics
MedicineChild HealthPediatricsPerinatology
2019English

Assessment of Utilization of Anticancer Drugs in Cancer Centre at Tertiary Care Hospitals in Telangana Region

International Journal of Research in Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy